IRIS PubliCatt

Favi, Evaldo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 659
EU - Europa 427
AS - Asia 91
AF - Africa 16
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 656
DE - Germania 169
SE - Svezia 83
CN - Cina 64
UA - Ucraina 61
IE - Irlanda 34
IT - Italia 28
CI - Costa d'Avorio 16
FI - Finlandia 16
IN - India 14
FR - Francia 13
GB - Regno Unito 13
IR - Iran 5
JP - Giappone 4
BR - Brasile 3
CA - Canada 3
BE - Belgio 2
CL - Cile 2
NL - Olanda 2
TR - Turchia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
KR - Corea 1
MN - Mongolia 1
NO - Norvegia 1
PT - Portogallo 1
Totale 1.200
Salva come PNG Salva come JPEG
Città #
Chandler 196
Ashburn 36
San Mateo 35
Dublin 33
Jacksonville 30
New York 29
Wilmington 25
Ann Arbor 23
Dearborn 20
Abidjan 16
Boston 13
Redwood City 12
Beijing 11
Fairfield 11
Nanjing 11
Nürnberg 11
Princeton 11
Houston 9
Lawrence 8
Milan 7
Nanchang 7
Augusta 6
Hebei 6
Woodbridge 6
Boardman 5
Zhengzhou 5
Cattolica 4
Guangzhou 4
Marseille 4
Shenyang 4
Costa Mesa 3
Helsinki 3
Leawood 3
Los Angeles 3
Seattle 3
São Paulo 3
University Park 3
Bremen 2
Brussels 2
Busto Arsizio 2
Cambridge 2
Fremont 2
Groningen 2
Izmir 2
Kish 2
Kunming 2
Lancaster 2
Las Vegas 2
Lomazzo 2
Mountain View 2
Norwalk 2
Phoenix 2
Pune 2
San Francisco 2
Saronno 2
Shanghai 2
Shenzhen 2
Tokyo 2
Toronto 2
Austin 1
Bangalore 1
Carson City 1
Castelnuovo Rangone 1
Changchun 1
Changsha 1
Dallas 1
Essen 1
Esslingen am Neckar 1
Fano 1
Haikou 1
Indiana 1
Jiaxing 1
Jinan 1
Lanzhou 1
Lisbon 1
Manchester 1
Monmouth Junction 1
Munich 1
Oslo 1
Ottawa 1
Paris 1
Rome 1
San Jose 1
Simi Valley 1
Tappahannock 1
Tianjin 1
Ulaanbaatar 1
Vancouver 1
Xian 1
Totale 693
Salva come PNG Salva come JPEG
Nome #
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 95
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 88
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 87
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 86
Significant improvement in patient survival after renal transplantation in the last decade. 81
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 80
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 80
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 78
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 68
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 63
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 59
Spontaneous renal allograft rupture complicated by urinary leakage: case report and review of the literature 57
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 55
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 49
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 48
Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine 44
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine 36
Higher Incidence of Acute Rejection in Renal Transplant Recipients With Low Everolimus Exposure 31
Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up 27
Totale 1.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.415
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 8 1
2019/2020155 29 7 14 4 5 2 22 3 14 6 29 20
2020/2021141 3 16 0 15 22 18 12 3 17 3 30 2
2021/2022148 5 15 1 3 6 2 3 32 10 15 18 38
2022/2023432 49 62 24 91 19 54 24 37 60 4 7 1
2023/2024117 11 45 3 16 3 25 6 1 2 5 0 0
Totale 1.212